Upsetting the apple CAR‐T (chimeric antigen receptor T‐cell therapy) ‐ sustainability mandates USA innovation

Jeremy Pantin, Minoo Battiwalla

Open source

DOI
10.1111/bjh.16685
Published
2020-05
Container
British Journal of Haematology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bjh.16685,
  title = {Upsetting the apple CAR‐T (chimeric antigen receptor T‐cell therapy) ‐ sustainability mandates USA innovation},
  author = {Jeremy Pantin and Minoo Battiwalla},
  year = {2020},
  journal = {British Journal of Haematology},
  doi = {10.1111/bjh.16685},
  url = {https://doi.org/10.1111/bjh.16685}
}

RIS

TY  - JOUR
TI  - Upsetting the apple CAR‐T (chimeric antigen receptor T‐cell therapy) ‐ sustainability mandates USA innovation
AU  - Jeremy Pantin
AU  - Minoo Battiwalla
PY  - 2020
JO  - British Journal of Haematology
DO  - 10.1111/bjh.16685
UR  - https://doi.org/10.1111/bjh.16685
ER  - 

APA

Pantin, J., & Battiwalla, M. (2020). Upsetting the apple CAR‐T (chimeric antigen receptor T‐cell therapy) ‐ sustainability mandates USA innovation. British Journal of Haematology. https://doi.org/10.1111/bjh.16685

Source records